BIOMERICA INC — Form 8-K
Filed October 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Item 5.02 reports a departure of director(s) or officer(s) and/or election of directors and appointment of officers, along with changes to compensatory arrangements. The filing provides no specific names, dollar amounts, dates of departure/appointment, or details of compensation changes—only that such an event occurred on or about 2026-10-09.
Why this rating
Standard officer/director transition disclosure with no quantitative detail. Without specifics on role criticality, compensation impact, or replacement, cannot assess materiality. Routine disclosure for a $6.6M market-cap company.
Extracted items
See more from October 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.